Hydrogen Water and Kidney Stones: What Recent Research Suggests

One in Ten People Will Form a Kidney Stone. Most Get Told the Same Three Words.

Drink more water. That is the advice a urologist has given kidney-stone patients for decades, and it is still the single best-supported intervention in the field. But a randomized trial published in September 2026 asked a sharper question: does it matter what kind of water? Researchers in Shanghai ran hydrogen-rich water head-to-head against a standard herbal treatment in one hundred kidney-stone patients — and reported a result worth reading carefully, not skimming past.

That is what this article does: report what the 2026 trial found, where it fits against the smaller body of hydrogen-kidney research before it, and why hydration remains the foundation no paper here is trying to replace. Some of this evidence is genuinely new. Some of it is still early. Both things are true.

Why Kidney Stones Form, and Where Oxidative Stress Fits In

Kidney stones do not appear from nowhere. They begin as microscopic crystals — usually calcium oxalate — that form when urine becomes supersaturated with stone-forming minerals. Most crystals wash out harmlessly. Stones happen when crystals stick around long enough to grow, and the question researchers have spent the last two decades chasing is why some kidneys let that happen and others don't.

The Crystal-Cell Collision

According to PubMed, Yasui and colleagues published a 2016 review in the International Journal of Urology laying out the mechanism in detail. They reported that calcium oxalate crystals adhere to renal tubular cells through a protein called osteopontin, and that this crystal-cell contact stresses the cell's mitochondria — specifically, it appears to trigger something called the mitochondrial permeability transition pore, a kind of internal alarm switch. When that switch flips, the cell's mitochondria collapse, oxidative stress spikes locally, and an apoptotic (cell-death) pathway activates in the tubular lining. That is the opening move in renal calcium crystallization, as the reviewers described it: not random buildup, but a specific, oxidative-stress-driven cascade set off by crystal contact.

Who's Most Likely to Form One

The same field has connected stone risk to a cluster of familiar conditions. According to PubMed, Khan published a 2012 review in Urological Research examining why kidney stones show up so often alongside obesity, hypertension, diabetes, and metabolic syndrome. The proposed common thread, again, was oxidative stress — a shared biochemical environment that appears to predispose people to several of these conditions at once, stone formation included. Khan's review noted that both tissue-culture and animal studies show reactive oxygen species generated specifically during the interaction between calcium oxalate crystals and renal epithelial cells, and that clinical studies have documented oxidative stress directly in the kidneys of people who form stones. None of that proves hydrogen water changes stone risk. It does explain why a selective antioxidant would end up on a nephrologist's radar.

The Selective-Antioxidant Research Behind Hydrogen Water

To understand why hydrogen turns up in kidney-stone research at all, you have to go back to the paper that started the whole field of molecular hydrogen study.

The 2007 Paper That Started the Field

According to PubMed, Ohsawa and colleagues published a study in Nature Medicine in 2007 — now cited thousands of times — reporting that molecular hydrogen appeared to act as a selective antioxidant. Working with cultured cells and a rat model of brain injury, they found that hydrogen reacted preferentially with the hydroxyl radical, one of the most destructive reactive oxygen species, while leaving alone the milder oxygen species that cells use for ordinary signaling. Most antioxidants don't discriminate that way; they blunt everything indiscriminately, useful signaling molecules included. The Ohsawa team reported something different: a small, fast-diffusing gas that seemed to target the damaging radicals specifically, and that could slip past cell membranes most antioxidant compounds never reach. That selectivity is the reason hydrogen shows up in oxidative-stress research across dozens of organ systems — the kidney included.

A Mouse Study That Targeted Kidney Stones Directly

One study took that idea and pointed it squarely at stone formation. According to PubMed, Si and colleagues published a 2021 study in Frontiers in Medicine using a mouse model of calcium-oxalate crystallization — mice fed a soluble oxalate diet to trigger the exact crystal-cell process Yasui's review described. The researchers reported that oral hydrogen-rich water was associated with reduced crystal deposition in the kidneys, less tubular injury, less fibrosis, and lower reactive-oxygen-species production compared to untreated mice. Serum markers of renal injury, inflammation, and oxidative stress — all elevated by the oxalate diet — were reduced in the hydrogen-water group. Using RNA sequencing, the team traced the effect to three specific signaling pathways: PI3K/AKT, NF-κB, and TGF-β, all of which were activated by oxalate exposure and dialed back by hydrogen-rich water. It is a mouse study, not a clinical trial. But it is the closest preclinical analog to the human trial that came five years later, and the mechanism it describes lines up neatly with the oxidative-stress story the urology literature already tells.

The 2026 Randomized Trial

Preclinical work sets up a hypothesis. The 2026 trial is what actually tested it in people with real kidney stones.

What the Trial Tested

According to PubMed, Yin and colleagues published a randomized controlled prospective clinical trial in Medical Gas Research in September 2026, run at the Seventh People's Hospital affiliated with Shanghai University of Traditional Chinese Medicine. One hundred patients with diagnosed kidney stones were randomly assigned to one of four groups — no additional treatment, hydrogen-rich water alone, hydrogen-rich water combined with a traditional Chinese herbal formula called Ye-Shi-Shi-Lin, or the herbal formula alone. All patients also received standard guideline-based care. Over twelve weeks, the researchers tracked imaging results, urine metabolism, renal function, and markers of inflammation and oxidative stress — a genuinely comprehensive workup, not a single blood draw. The trial was registered with the International Traditional Medicine Clinical Trial Registry (ITMCTR2025001446), a detail worth noting because registered trials commit to their methods before they see the results.

What Researchers Reported

The results were not uniform, and we'll report them exactly as the researchers did. The overall treatment-effective rate was 28% with no treatment, 32% with hydrogen-rich water alone, 76% with the herbal formula alone, and 80% with the two combined. Hydrogen-rich water by itself produced a modest improvement; its clearest specific signal was on glutathione reductase, an enzyme the body uses to regenerate one of its core internal antioxidants, improving in a way the herbal formula alone did not. Combined with the herbal treatment, hydrogen-rich water was associated with the strongest results in the trial — better oxidative-stress markers, improved uric-acid and urinary-stone metabolic factors, and better-preserved renal tubular function than either treatment alone. That is a real, human, randomized signal. It is also one trial, at one hospital, and it deserves replication.

Two More Threads in the Hydrogen-Kidney Literature

Kidney stones are one corner of a broader research area. Two other lines of hydrogen-kidney work round out the picture — one about a specific clinical stressor, one about the field as a whole.

Hydrogen and Chemotherapy-Related Kidney Stress

Cisplatin is one of the most effective chemotherapy drugs available, and one of the hardest on the kidneys — its dosing is limited specifically because of nephrotoxicity. According to PubMed, Nakashima-Kamimura and colleagues published a study in Cancer Chemotherapy and Pharmacology in 2009 testing whether hydrogen could soften that side effect in mice. They reported that both inhaled hydrogen gas and hydrogen-rich drinking water reduced cisplatin-induced kidney injury — lower serum creatinine and blood urea nitrogen, less apoptosis in renal tissue, better survival and body-weight outcomes — without blunting cisplatin's ability to fight tumors in the same animals. The researchers described the finding as a potential way to mitigate one specific, well-documented drug side effect, and called for further study. It is not a kidney-stone study, and it is a mouse study. It is included here because it was one of the earliest reports that hydrogen-rich drinking water — not just inhaled gas — was associated with measurable changes in kidney tissue in an animal model.

A Broader Review of Hydrogen in Kidney Disease

Zoom out further and a 2022 review captures where the field stood before the 2026 trial arrived. According to PubMed, Wang and colleagues published a review in Kidney Diseases surveying hydrogen's proposed role across acute kidney injury, chronic kidney disease, drug-induced nephrotoxicity, and dialysis-related complications. The reviewers described antioxidant, anti-inflammatory, and anti-apoptotic mechanisms consistent with everything reported above. Their honest caveat: most of the supporting evidence is preclinical, and large-scale randomized trials are still required before routine clinical use. That caveat was written before the 2026 stone trial existed — exactly the kind of trial the reviewers were calling for.

Hydration Still Does Most of the Work

None of the hydrogen research changes the single best-documented fact about kidney stones: water intake is the intervention with the strongest evidence on recurrence.

The Classic Water-Intake Trial

According to PubMed, Borghi and colleagues published a five-year randomized prospective study in The Journal of Urology back in 1996 that remains a benchmark in the field. They followed 199 first-time calcium-stone formers, randomizing half to a high-water-intake regimen and leaving the other half untreated. Over five years, stone recurrence was documented in 12 of 99 patients in the high-water-intake group compared with 27 of 100 in the untreated group — roughly half the recurrence rate, from water volume alone. The average time to a recurrence, when one happened, was also longer in the water group: nearly 39 months versus about 25. The researchers' conclusion has held up for three decades: low urine volume is a real, independent risk factor for stone formation, and a large water intake is the first-line therapy for preventing recurrence. Any conversation about hydrogen water and kidney stones has to start from that baseline. Hydration is the floor, not a footnote.

Where does that leave the research? Established: oxidative stress plays a documented, specific role in how calcium oxalate crystals injure kidney tissue, and molecular hydrogen has a decades-deep evidence base as a selective antioxidant. Emerging: a 2026 randomized trial in one hundred stone patients reported that hydrogen-rich water, especially combined with standard treatment, improved oxidative-stress markers and urinary metabolism over twelve weeks — a genuinely new, controlled data point in a field that was almost entirely preclinical before it. Still open: whether that signal replicates elsewhere, which is exactly what a single-site trial is supposed to prompt, not settle. No adverse events were reported in the human trials discussed here, and none of this research studied hydrogen-rich water as a replacement for ordinary water intake.

Frequently Asked Questions

What has research reported on hydrogen water and kidney stones? The research is still early. A 2026 randomized controlled trial in Medical Gas Research reported that hydrogen-rich water, especially when combined with a standard herbal treatment, was associated with changes in oxidative-stress markers and urinary metabolism in kidney-stone patients over twelve weeks. That is one trial at one hospital and has not been replicated. Hydrogen-rich water is not a treatment for kidney stones, and the trial did not test it as a substitute for adequate water intake, which remains the best-documented factor in stone recurrence.

What did the 2026 clinical trial on hydrogen water and kidney stones actually find? Researchers randomized 100 kidney-stone patients into four groups over twelve weeks. Hydrogen-rich water alone showed a modest difference from no treatment and a specific change in glutathione reductase, an antioxidant enzyme. Combined with a standard herbal treatment, hydrogen-rich water was associated with the largest differences in the trial for oxidative-stress markers, urinary metabolic factors, and renal tubular function.

Can hydrogen water replace drinking enough water for kidney stone prevention? No. A five-year randomized trial from 1996 reported that high water intake alone roughly halved stone recurrence, and that finding remains the foundation of stone prevention today. Hydrogen-rich water has only been studied as a possible addition on top of adequate hydration, never as a substitute for it.

Were adverse events reported in the hydrogen water trials covered here? No adverse events were reported in the human trials covered in this article. Anyone with a diagnosed kidney-stone condition should follow the guidance of a qualified healthcare provider, particularly around fluid intake, diet, and any prescribed treatment.

Further Reading

For the broader literature, browse PubMed's results for hydrogen-rich water and kidney stones.

• Yin et al. (2026), Medical Gas Research. PMID: 42734448. The randomized trial at the center of this article — 100 kidney-stone patients, reporting the largest differences in the group that received hydrogen-rich water paired with a standard herbal treatment.
• Wang et al. (2022), Kidney Diseases — a review. PMID: 35527991. A wide-angle survey of hydrogen's proposed mechanisms across kidney disease, useful for readers who want the full landscape rather than one condition.
• Yasui et al. (2016), International Journal of Urology — a review. PMID: 27539983. Explains, in molecular detail, how calcium oxalate crystals trigger oxidative stress inside kidney cells — the mechanism the hydrogen research is trying to interrupt.
• Khan (2012), Urological Research — a review. PMID: 22213019. Connects stone formation to obesity, diabetes, and metabolic syndrome through a shared oxidative-stress pathway.
• Si et al. (2021), Frontiers in Medicine. PMID: 34490303. The mouse study that first tested hydrogen-rich water directly against oxalate-induced kidney crystallization.
• Nakashima-Kamimura et al. (2009), Cancer Chemotherapy and Pharmacology. PMID: 19148645. An early mouse study reporting that hydrogen-rich drinking water — not just inhaled gas — was associated with less cisplatin-induced kidney injury.
• Borghi et al. (1996), The Journal of Urology. PMID: 8583588. The five-year randomized trial establishing that water intake alone roughly halves kidney-stone recurrence — still the field's benchmark study.

References

Ohsawa I, Ishikawa M, Takahashi K, et al. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine, 13(6):688–694. PMID: 17486089. DOI: 10.1038/nm1577.

Yasui T, Okada A, Hamamoto S, et al. (2016). Pathophysiology-based treatment of urolithiasis. International Journal of Urology, 24(1):32–38. PMID: 27539983. DOI: 10.1111/iju.13187.

Khan SR. (2012). Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urological Research, 40(2):95–112. PMID: 22213019. DOI: 10.1007/s00240-011-0448-9.

Si Y, Liu L, Cheng J, et al. (2021). Oral hydrogen-rich water alleviates oxalate-induced kidney injury by suppressing oxidative stress, inflammation, and fibrosis. Frontiers in Medicine, 8:713536. PMID: 34490303. DOI: 10.3389/fmed.2021.713536.

Yin Y, Wang J, Lian F, et al. (2026). Hydrogen-rich water combined with traditional Chinese medicine compound in the treatment of kidney stones: a randomized controlled prospective clinical trial. Medical Gas Research, 17(1):63–69. PMID: 42734448. DOI: 10.4103/mgr.MEDGASRES-D-26-00067.

Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. (2009). Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemotherapy and Pharmacology, 64(4):753–761. PMID: 19148645. DOI: 10.1007/s00280-008-0924-2.

Wang B, Li Z, Mao L, et al. (2022). Hydrogen: a novel treatment strategy in kidney disease. Kidney Diseases, 8(2):126–136. PMID: 35527991. DOI: 10.1159/000520981.

Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. (1996). Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. The Journal of Urology, 155(3):839–843. PMID: 8583588.

To keep going, our explainer on what hydrogen water actually is covers the chemistry from the ground up, our companion piece on hydrogen water and kidney health looks at the organ more broadly beyond stone formation, our review of hydrogen water and inflammation goes deeper on the oxidative-stress and inflammatory-signaling research this article draws on, and our piece on hydrogen water and gout covers a related uric-acid and urinary-system thread.

This article is provided for educational and general wellness purposes only and should not be considered medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.